Member Info for Kashdog

Anybody going to talk about Lloyds…..or is everyone on here self righteous, opinionated politico pricks, whatever your denomination.

LTT, great video from Beacon, bought back some good and bad memories having worked on many offshore EPIC projects globally.

LTH here from FOG days …..tucked away in the bottom drawer with a realistic target price in mind.👍

Very wordy communication can be distilled down to more dilution.

Note the wording around the ECT claim about if the claim is found for, then the expenses incurred in chasing the compensation will be deducted. Given that it will take many years, not just to get a finding but if it is successful, which is highly unlikely, as Ascent refused to undertake an EIA then it will take many more years to settle.

In the meanwhile any money you have invested here is dead for years to come….and the most likely outcome in my view is dissolution of the company.

Moonparty, nice one on Calculus, finally evidenced for me.

Only 8 weeks to the opportunity with the ISA but either way if, unlikely as it is at the moment, that it does fly then it’s a win / win for me and many others on here.

Thanks Ping!

I also have a query, after looking at Enyo Law’s website, I can find no reference to Ascent Resources. It used to show the title of the claim and the name of the Lawyer representing but I could not find any mention of AST.

Are they still representing AST or have they removed themselves from the claim?

VD, I agree with you!… my wondering question 24 hrs ago was based on the CEO of Oracle’s statement.

Should Scancell look at adopting AI to fast track data into commercial probability. Just musing! 😁

Wondering if the impact of Stargate AI will overtake the pace of traditional trials and show Scancell as progressing at Snails pace.

It seems that Stargate AI could identify an individual MRNA vaccine within 48hrs. 🤔

AST getting more sophisticated with their scam business!…market cap now at £5.49 million which at current SP means there are (if my maths are right) circa 267,000,000 shares in existence with little or no income.

AST do not even have an office or staff just a clever BoD.

Look back at all the enterprises they have supposedly initiated and then count how many have made a single penny.

Those that think the SP will reach 5p which would value the company at somewhere around £12 million must know something that credible investors don’t.

They have no tangible assets of any worth. Where is the value here?…I just don’t see it and believe me I have looked.

This new guy has a background in international arbitration. Could it be that shortly AST will be told by Enyo Law that they will not continue to support the claim against the Slovenian Government as it has little chance of succeeding and are withdrawing from the process.

So Thieffrey would be the last throw of the dice. Just a thought!…🤔

For the first time, this is looking like a “true to form” AIM listed company.

It feels like a rushed dilution!…It seemed to me that the company was expecting nothing but good news on trials and also expecting milestone payments in the near future. Both events you could imagine would lift the SP, at which point, the placing and the retail price might have been higher.

My trust in this management team is somewhat eroded so have moved my opinion from “strong buy” to “hold”

I found the RNS disappointing as I was expecting a better ORR based on previous figures put out. I then think about the cash runway and how that could impact on progress. Potential income is just that, it’s not cash in hand. Trial completion dates pushed back doesn’t help convince institutional investors.

I know I’m skimming the surface here as I don’t do detail but regardless of my thinking that the points I have made above are possible reasons for a stagnating SP, I remain convinced that this is a good investment.

The world is looking for a cancer cure, it don’t mean nothing that a Kennedy thinks otherwise. Proof of concept and delivery of that cure is all that is needed! 👍

There is a mix of fact, wishful thinking and emotion on this BB. LTH’s are no longer investors but are real gamblers!

Newcomers will trade and investors will trade but most LTH’s will hold in the hope that potential will morph in to real profit.

I think most contributors to this board are wishful thinkers and keep promoting that wishful thinking by daily contributions to this BB.

I am not saying they are wrong, in fact I have a significant holding here.

There seems to be a group that thinks data is the key to untold wealth but the reality is that a major pharma making an offer on potential positive trial outcomes, call it “data” if you must, is the only route to that wealth.

So much can go wrong here that trading on ebb and flow could be and has been beneficial.

The cash runway is an indicator that genuine investors should not ignore. Watch for updates and trade wisely. Easier said than done I know but not impossible!

Wobble, if you read the RNS from the 2nd April 2024 you may not be so convinced of how far removed the JV partners are from the Slovenian government.

For transparency, I bailed out of this some years ago with a significant loss. My continued interest is due to the fact that my wife holds a few in her S&S ISA, not enough to make it worth her while to sell but enough for me to retain a casual interest.

To be clear, I hope that the PI’s and LTH’s do get something out of this and I wish them all the best of luck with it as nobody wants to see, or hear, about financial loss.

However, having held shares here in the past and through my own interpretation of what has or is happening, I truly believe that there is no future with this share.

Understood Wobble but either way you cut it, it would be many years down the road!!!

Wobble, I watched the video and found the point on “resource nationalism” interesting. Most of the rest was a sales pitch by Tim Foden.

Not sure I understand your comment about Slovenian assets in the US.

As for Enyo Law’s investment in this dispute, they don’t always get it right …I gave an example of one of their failures in a previous post on here!

We have different views / opinions!… you stick with yours and I with mine!!

Wobble, you clearly have a better understanding than me on the “technicalities” of a claim under the BIT but regardless of that, I think the outcome will be the same as I have indicated

You are also quite clear that AST could, in the end, seize assets outside of Slovenia but I agree with Kenj’s thoughts that the EU would support a member of that community against the UK, which leaves the possibility of AST seizing UK based Slovenian assets, which begs the question “does Slovenia have any UK assets”?……and if it’s ok with you, I will bang on about the “metals business” as much as I want to, you pompous tw*t.

There is potential income also, the value of which is as yet unknown until mid January when a “major international biotechnology company, will exclusively evaluate a Scancell investigational anti-glycan monoclonal antibody for development of novel therapeutic products.

Under the terms of the agreement, Scancell has granted the company seven months exclusivity for evaluation, which includes an $1M exclusivity payment payable within 30 days.”

This was information released with an RNS on the 12th June, the seven month end date is just after Xmas, so anyone’s guess on what the value of that might be.

I cannot imagine that a raise would be considered until that potential value is known.

Now more than a quarter of a billion shares issued with no real manageable projects in place, a non existent “metals” business, a non existent “Hispanic” business, it should be no surprise to anyone when this “pretend” business folds, as I am sure it will.

Long term shareholders will no doubt hang on in the forlorn hope that Enyo Law will fill the AST coffers but the realistic odds of that happening, in my opinion, are slim. If it does happen, it will be years away because the Slovenian government, if found against, will vigorously initiate appeal after appeal and if still found against, will just refuse to pay.

This company will only exist with continuous fundraising and dilution in order to pay this joke of a BoD.